Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Selection and in vitro and in vivo...
Journal article

Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin

Abstract

The 57-amino acid Kunitz Protease Inhibitor (KPI) domain of Protease Nexin 2 inhibits Factor XIa (FXIa) and other proteases. We previously fused KPI to human serum albumin (KPIHSA). KPIHSA inhibits coagulation Factor XIa (FXIa) 6-fold more rapidly than plasmin. We screened a bacterial expression library of KPI variants randomized at M17, and selected M17D as having the highest anti-FXIa: antiplasmin activity ratio. Expressed as HSA fusion …

Authors

Eltringham-Smith LJ; Bhakta V; Sheffield WP

Journal

Journal of Biotechnology, Vol. 330, , pp. 61–69

Publisher

Elsevier

Publication Date

March 2021

DOI

10.1016/j.jbiotec.2021.02.016

ISSN

0168-1656